Spire Wealth Management Makes New $243,000 Investment in Structure Therapeutics Inc. (NASDAQ:GPCR)
Spire Wealth Management bought a new stake in Structure Therapeutics Inc. (NASDAQ:GPCR – Free Report) in the 4th quarter, Holdings Channel.com reports. The fund bought 8,949 shares of the company’s ...
Brokerages Set Structure Therapeutics Inc. (NASDAQ:GPCR) Target Price at $81.29
Shares of Structure Therapeutics Inc. (NASDAQ:GPCR – Get Free Report) have been assigned an average rating of “Buy” from the ...
Nature5d
The weight-loss drugs being tested in 2025: will they beat Ozempic?
In the first half of 2025, Ozempic developer Novo Nordisk in Bagsværd, Denmark, expects results from a second phase III trial ...